An interventional study of PRP injection and corticosteroid injection in Pes Anserine Bursitis, Steroid Injection and PRP Injection, sponsored by Ramathibodi Hospital. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-11.
Sponsored by Ramathibodi Hospital · Not applicable, Interventional, and Treatment
The goal of this research is to study the efficacy of treatment between PRP injection and corticosteroid injection in patients with pes anserinus bursitis. The research question is whether PRP can reduce pain more effectively than corticosteroids.
The study is divided into two groups: one group receiving PRP injections and the second group receiving corticosteroid injections. Treatment outcomes will be monitored at four time points: baseline, 4 weeks, 12 weeks, and 24 weeks. The outcomes will be measured using the VAS and WOMAC scores.
Randomization of patient with pes anserinus bursitis at opd od ramathibodi hospital.
Objective : to study the efficacy of treatment between PRP injection and corticosteroid injection in patients with pes anserinus bursitis
Medhods :
A randomized controlled trial , Single blinded Participants : Patients with pes anserinus bursitis Randomization : Randomization will be performed using the software STATA 16.0 (StataCorp, College Station, Texas, USA). A various blocked randomization method
Interventions and control :
Allocation and concealment :
A central randomization service will prepare sealed envelopes containing the assigned treatment for each patient.
The envelopes will be kept in secure location until Break the concealment at outpatient orthopedics department , Ramathibodi hospital
Blinding :
Randomized controlled trial study, Single blinded The assessor who will be follow up the patients, will be blinded to the group assignments.
Outcome measures:
Visual Analogue Scale (VAS) , Womac scores
Follow up:
at 4 weeks, 12 weeks, and 24 weeks after injection.
Statistic analysis:
STATA 16.0, StataCorp, College Station, Texas, USA Analysis Demographic data : mean, SD Mean difference in patient-relevant outcomes : Independent T- test
383 studies on the registry are indexed under Bursitis; 111 are open to participants now.
This study's planned enrollment of 24 is below the median of 44 across 346 interventional studies indexed under Bursitis.
Browse Bursitis studies →Ramathibodi Hospital is the lead sponsor of 63 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
receive pes anserinus PRP injection
Drug: PRP injection
receive pes anserinus corticosteroid injection
Drug: corticosteroid injection
Receive pes anserinus PRP injection
Receive pes anserinus corticosteroid injection
Visual analogue scale (VAS)
Pain relief outcome : Visual analogue scale (VAS) scale 0(minimum pain) to 10(maximum pain)
Time frame: 6 months
WOMAC score
Functional outcomes : The Western Ontario and McMaster Universities Arthritis Index(WOMAC) version 3.01 Thai version
Time frame: 6 months
No study locations are listed for this record.
Plan to share: No
This study is not yet recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Platelet rich plasma
Ramathibodi Hospital